The news landed like a thunderclap in a San Francisco conference room on June 30, 2026. Anthropic, the artificial intelligence company behind the cutting-edge Claude model, announced it will launch its own preclinical drug-discovery programs targeting neglect…
Read Full ArticleThis article was originally published on Activistpost.com. Click the button above to read the complete article.
